Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 35, 2024 - Issue 1
Submit an article Journal homepage
1,214
Views
0
CrossRef citations to date
0
Altmetric
Article

Leptin induces altered differentiation of keratinocytes by inducing insulin resistance: implications for metabolic syndrome-induced resistance of psoriatic therapy

Rui WangDepartment of Dermatology, First Medical Centre of Chinese PLA General Hospital, Beijing, ChinaView further author information
,
Chongli YuDepartment of Dermatology, First Medical Centre of Chinese PLA General Hospital, Beijing, ChinaView further author information
,
Zijie TangDepartment of Dermatology, First Medical Centre of Chinese PLA General Hospital, Beijing, ChinaView further author information
,
Jie SunDepartment of Dermatology, First Medical Centre of Chinese PLA General Hospital, Beijing, ChinaView further author information
,
Youlin WangDepartment of Dermatology, First Medical Centre of Chinese PLA General Hospital, Beijing, ChinaView further author information
,
Zhenkai ZhaoDepartment of Dermatology, First Medical Centre of Chinese PLA General Hospital, Beijing, ChinaView further author information
,
Biwen LinDepartment of Dermatology, First Medical Centre of Chinese PLA General Hospital, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Chengxin LiDepartment of Dermatology, First Medical Centre of Chinese PLA General Hospital, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2309305 | Received 19 Jul 2023, Accepted 16 Oct 2023, Published online: 31 Jan 2024

References

  • Schön MP. Adaptive and innate immunity in psoriasis and other inflammatory disorders. Front Immunol. 2019;10:1. doi: 10.3389/fimmu.2019.01764.
  • Korman NJ. Management of psoriasis as a systemic disease: What is the evidence? Br J Dermatol. 2020;182(4):840–5. doi: 10.1111/bjd.18245.
  • Peralta C, Hamid P, Batool H, et al. Psoriasis and metabolic syndrome: comorbidities and environmental and therapeutic implications. Cureus. 2019;11(12):e6369. doi: 10.7759/cureus.6369.
  • Rui W, Xiangyu D, Fang X, et al. Metabolic syndrome affects narrow-band UVB phototherapy response in patients with psoriasis. Medicine. 2017;96(50):e8677. doi: 10.1097/MD.0000000000008677.
  • Gisondi P, Bellinato F, Girolomoni G, et al. Pathogenesis of chronic plaque psoriasis and its intersection with cardio-metabolic comorbidities. Front Pharmacol. 2020;11:117. doi: 10.3389/fphar.2020.00117.
  • Xue K, Liu H, Jian Q, et al. Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro–a possible reason for increased severity of psoriasis in patients with a high body mass index. Exp Dermatol. 2013;22(6):406–410. doi: 10.1111/exd.12162.
  • Spravchikov N, Sizyakov G, Gartsbein M, et al. Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes. 2001;50(7):1627–1635. doi: 10.2337/diabetes.50.7.1627.
  • Wertheimer E, Trebicz M, Eldar T, et al. Differential roles of insulin receptor and insulin-like growth factor-1 receptor in differentiation of murine skin keratinocytes. J Invest Dermatol. 2000;115(1):24–29. doi: 10.1046/j.1523-1747.2000.00008.x.
  • Sadagurski M, Nofech‐Mozes S, Weingarten G, et al. Insulin receptor substrate 1 (IRS‐1) plays a unique role in normal epidermal physiology. J Cell Physiol. 2007;213(2):519–527. doi: 10.1002/jcp.21131.
  • Buerger C, Richter B, Woth K, et al. Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis. J Invest Dermatol. 2012;132(9):2206–2214. doi: 10.1038/jid.2012.123.
  • Polyzos SA, Kountouras J, Mantzoros CS. Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism. 2015;64(1):60–78. doi: 10.1016/j.metabol.2014.10.012.
  • Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–6223. doi: 10.3390/ijms15046184.
  • Pinto Lde F, Compri CM, Fornari JV, et al. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. Liver Int. 2010;30(4):603–610. doi: 10.1111/j.1478-3231.2009.02200.x.
  • Kamohara S, Burcelin R, Halaas JL, et al. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389(6649):374–377. doi: 10.1038/38717.
  • Benomar Y, Naour N, Aubourg A, et al. Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase- dependent mechanism. Endocrinology. 2006;147(5):2550–2556. doi: 10.1210/en.2005-1464.
  • Burgos-Ramos E, Chowen JA, Arilla-Ferreiro E, et al. Chronic Central leptin infusion modifies the response to acute Central insulin injection by reducing the interaction of the insulin receptor with IRS2 and increasing its association with SOCS3. J Neurochem. 2011;117(1):175–185. doi: 10.1111/j.1471-4159.2011.07191.x.
  • Singh S, Bhansali A. Randomized placebo control study of insulin sensitizers (metformin and pioglitazone) in psoriasis patients with metabolic syndrome (topical treatment cohort). BMC Dermatol. 2016;16(1):12. doi: 10.1186/s12895-016-0049-y.
  • Zhao S, Zhu Y, Schultz RD, et al. Partial leptin reduction as an insulin sensitization and weight loss strategy[J]. Cell Metab. 2019;30(4):706–719.e6. doi: 10.1016/j.cmet.2019.08.005.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.